| 05/18/2026 8:11 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 8:13 AM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 05/15/2026 8:03 AM | Woodline Partners LP (1784547) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:06 PM | XOMA Royalty (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:15 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D | |
| 04/30/2026 1:38 PM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 04/29/2026 4:43 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D/A | |
| 04/27/2026 6:37 PM | LIGAND PHARMACEUTICALS INC (886163) Filer XOMA Royalty (791908) Filer | Form DEFA14A | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 04/27/2026 3:01 PM | XOMA Royalty (791908) Filer | Form 8-K/A | |
| 04/27/2026 7:16 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for XOMA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for XOMA Royalty and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/27/2026 7:19 AM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 04/22/2026 3:30 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:13 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:30 PM | LIMBER JOSEPH M (1216023) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 4:34 PM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 03/30/2026 4:35 PM | XOMA Royalty (791908) Filer | Form ARS | |
| 03/27/2026 1:14 PM | VANGUARD GROUP INC (102909) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 03/26/2026 3:30 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:45 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:38 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 03/02/2026 5:04 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:36 PM | MORGAN STANLEY (895421) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 4:14 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 01/15/2026 3:25 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:35 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:58 AM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 01/12/2026 6:00 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:05 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T | |
| 12/15/2025 7:36 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-C | |
| 12/05/2025 8:15 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 6:50 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
Read now. Do not delete. You’ve been warned. (Ad) Three Nobel Prize Winners expose this once-in-a-generation wealth shift:
“Don’t Say I Didn’t Warn You”
Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. Don’t be left behind. Click here now. |
| 11/21/2025 7:03 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 6:16 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 11/12/2025 6:46 AM | XOMA Royalty (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:46 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 11:22 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 10/03/2025 4:24 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 4:00 PM | XOMA Royalty (791908) Filer | Form 424B5 | |
| 10/03/2025 4:03 PM | XOMA Royalty (791908) Filer | Form 424B5 | |
| 10/02/2025 3:35 PM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 09/26/2025 4:29 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/23/2025 4:32 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | BURNS THOMAS M. (1638479) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:32 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:13 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/17/2025 8:10 AM | HilleVax, Inc. (1888012) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 09/12/2025 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 3:07 PM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 09/03/2025 4:15 PM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 08/18/2025 7:23 AM | HilleVax, Inc. (1888012) Subject XOMA Royalty (791908) Filed by | Form SC TO-T | |
| 08/15/2025 7:49 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T | |
| 08/14/2025 3:10 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 08/14/2025 3:11 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 6:45 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 6:41 AM | XOMA Royalty (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/11/2025 8:15 AM | Turnstone Biologics Corp. (1764974) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 08/06/2025 11:19 AM | FMR LLC (315066) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 08/04/2025 7:05 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-C | |
| 08/04/2025 6:32 AM | HilleVax, Inc. (1888012) Subject XOMA Royalty (791908) Filed by | Form SC TO-C | |
| 07/29/2025 1:54 PM | VANGUARD GROUP INC (102909) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 07/11/2025 5:05 AM | Turnstone Biologics Corp. (1764974) Subject XOMA Royalty (791908) Filed by | Form SC TO-T | |
| 07/02/2025 3:30 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 7:00 AM | Turnstone Biologics Corp. (1764974) Subject XOMA Royalty (791908) Filed by | Form SC TO-C | |
| 06/06/2025 3:14 PM | MORGAN STANLEY (895421) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 05/23/2025 3:46 PM | Kosacz Barbara (1763316) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:47 PM | Franklin Heather L (1436658) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:47 PM | Hernday Natasha (1780547) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:47 PM | PERRY MATTHEW D (1454337) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:47 PM | LIMBER JOSEPH M (1216023) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:48 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/23/2025 3:48 PM | Kosacz Barbara (1763316) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2025 6:11 PM | BURNS THOMAS M. (1638479) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2025 6:11 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2025 5:52 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D/A | |
| 05/20/2025 5:56 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |